The Microbicide Trials Network (MTN) was established in 2006 by the National Institute of Allergy and Infectious Diseases (NIAID), with co-funding by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the US National Institutes of Health. As an HIV/AIDS clinical trials network, the mission of the MTN was to conduct rigorous trials of promising microbicides – products used in the vaginal or rectum to protect against the sexual transmission of HIV.
On November 30, 2021, MTN’s tenure as a NIH-funded clinical trials network came to an end. The DELIVER (MTN-042) study, which remains ongoing, and certain other activities will continue to be supported by NIAID for another year via funding allocated through the HIV Prevention Trials Network.
Quick links to specific segments:
Due to the sheer volume of content and personal messages received, it simply wasn’t feasible to include everything in its entirety into the final program, including the videos listed below, which you may view in their original form.
Featuring: Imogen Hawley, Ariana Katz, Tozoe Marton, Ali Minnis, Liz Montgomery, Sarah Roberts, Marie Stoner, and Alinda Young, with Mary Kate Shapley-Quinn and Erica Browne (in absentia)